Amundi
- SEC CIK
- 0001330387
- Latest filing
- Aug 26, 2026
RCKT holding history
Rocket Pharmaceuticals, Inc. in every 13F filed by Amundi, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RCKT overviewAll 13F holders of RCKTFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −3,973−100.0% | Sold out | Holders |
| Q1 2025 | 3,973 | $22.1K | <0.1% | +16+0.4% | Added | Holders |
| Q4 2024 | 3,957 | $46.7K | <0.1% | +118+3.1% | Added | Holders |
| Q3 2024 | 3,839 | $66.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 3,839 | $76.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 3,839 | $90.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 3,839 | $113.0K | <0.1% | −813−17.5% | Reduced | Holders |
| Q3 2023 | 4,652 | $81.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 4,652 | $92.9K | <0.1% | −767−14.2% | Reduced | Holders |
| Q1 2023 | 5,419 | $89.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 5,419 | $110.9K | <0.1% | +1,534+39.5% | Added | Holders |
| Q3 2022 | 3,885 | $67.0K | <0.1% | +3,885 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −3,836−100.0% | Sold out | Holders |
| Q4 2021 | 3,836 | $71.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 3,836 | $115.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 3,836 | $170.0K | <0.1% | – | No prior filing | Holders |